PillsCard
Reading from 50+ regulators…
Loading the latest data0%
PillsCard
Reading from 50+ regulators…
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Atorvastatin | Rosuvastatin | |
|---|---|---|
| Active Substances | ATORVASTATIN | ROSUVASTATIN |
| ATC Code | C10AA05 | C10AA07 |
| Form | TABLET | TABLET, FILM COATED |
| Dosage | 20 mg/1 | 5 mg/1 |
| Route | ORAL | ORAL |
| Manufacturer | DirectRX | ScieGen Pharmaceuticals, Inc. |
| Indications | This medication is an HMG-CoA reductase inhibitor, also known as "statin”, prescribed for hyperlipidemia. | This medication is used to reduce the cholesterol in patients with obesity problem. It is a HMG-CoA reductase inhibitor (statin). It slows the production of cholesterol in the body. |
| Side Effects | Most Common - Nose inflammation, joint pain, diarrhea, pain in extremity, urinary tract infection, indigestion, nausea, muscle and bone pain, muscle spasms, sleeplessness and throat pain. Body as a whole - Uneasiness and fever. Gastrointestinal - Abdominal discomfort, eructation, flatulence, liver inflammation and bile obstruction. Musculoskeletal - Muscle fatigue, neck pain and joint swelling. Metabolic - Increase in liver enzymes level, abnormal liver function tests and increased sugar level. Central Nervous system - Dizziness, depression, fatigue, peripheral neuropathy and abnormal dreams. Respiratory - Nose bleed. Skin - Hives. Eye and ENT - Blurred vision and ringing in the ear. Genitourinary - Urinary tract infection. Musculoskeletal - Immune-mediated necrotizing myopathy (IMNM). | Central Nervous System - Headache, dizziness, tingling, lack of energy, sleeplessness, depression. Gastrointestinal - Nausea, vomiting, abdominal pain, constipation Miscellaneous - Muscle pain, chest pain, swelling of tissues, skin rash, , protein in urine. ♦ Musculoskeletal - Immune-mediated necrotizing myopathy. |
| Warnings | • Caution should be exercised in patients with history of low blood pressure, serious infection, seizures, electrolyte problems, liver problems, alcohol abuse, any allergy, during pregnancy and breastfeeding. • It may cause dizziness, do not drive a car or operate machinery while taking this medication. • Avoid alcohol consumption. • Follow the diet and exercise program as directed by your physician. • Monitor blood cholesterol level and liver functions regularly while taking this medication. | • Not to be used in patient with acute, serious condition suggestive of muscular diseases(myopathy) or predisposing to the development of kidney failure secondary to rapid breakdown of skeletal muscle(rhabdomyolysis) e.g. sepsis, hypotension, major surgery, trauma, severe metabolic, endocrine and electrolyte disorders or uncontrolled seizures. Caution should be exercised in patients with history of liver disease and alcoholism. • Discontinue treatment if there is marked or persistent increase in serum aminotransferase concentrations, significant increase in creatinine phosphokinase or evidence of muscular diseases. ♦ Monitor liver function regularly while taking this medication . |
Atorvastatin (INN: ATORVASTATIN, ATC C10AA05) and Rosuvastatin (INN: ROSUVASTATIN, ATC C10AA07) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.